Patient-reported diagnostic pathways and disclosure experiences in autosomal dominant polycystic kidney disease (ADPKD)

A large French survey of patients with autosomal dominant polycystic kidney disease reveals that diagnostic disclosure frequently occurs outside nephrology care, often by radiologists, and is associated with poor tact and inadequate information, leading to significant psychological distress and negative patient experiences.

The Gist

Imagine your body is a bustling city, and for some people, that city has a hidden blueprint for a specific problem: Autosomal Dominant Polycystic Kidney Disease (ADPKD). This is a genetic condition where fluid-filled sacs (cysts) slowly grow in the kidneys, like weeds taking over a garden.

This paper is like a giant survey asking 1,000 people with this condition: "How did you find out you had this, and how did it feel?"

Here is the story they told, broken down into simple parts:

1. The "Wrong Messenger" Problem

In an ideal world, finding out you have a serious health condition is like having a trusted guide walk you through a dark forest. You'd expect a specialist (a nephrologist, or kidney doctor) to be that guide.

However, the survey found that for nearly half of the people, the news was delivered by a radiologist.

• The Analogy: Imagine you go to the library to check out a book, and instead of a librarian telling you about it, the photocopier suddenly prints a note saying, "You have a rare disease."
• Radiologists are experts at taking pictures (scans) of your insides, but they aren't always trained to deliver life-changing news with the right care. The study found that when radiologists broke the news, patients were 2.5 times more likely to feel the doctor was clumsy, cold, or insensitive ("poor tact").

2. The "Bad News" Experience

When the news is delivered poorly, it leaves a scar.

• The Stat: About 29% of people said the whole experience was "very negative."
• The Cause: It wasn't just who told them, but how. If the doctor was tactless or if the explanation was confusing (like reading a manual written in a foreign language), the patient felt lost and scared.
• The Metaphor: Think of it like being handed a map to a treasure hunt, but the map is torn, the ink is smudged, and the person handing it to you just shrugs and walks away. That leaves you feeling anxious and alone.

3. The Timing Dilemma

The survey also asked, "Was the news given at the right time?"

• 67% said, "Yes, it was just right."
• 18% felt it was too early (like being told about a storm before you even left the house).
• 15% felt it was too late (like being told about the storm after you were already soaked).
• Even when the timing was "right," many people (over a third) felt immediate emotional distress or had unmet psychological needs. They were told the "what," but no one helped them with the "how do I live with this?"

The Big Takeaway

The researchers are saying: We need a better playbook.

Right now, the system is a bit chaotic. A patient might get a scan, see a scary result on a screen, and have a technician or radiologist drop a heavy bombshell on them without a safety net.

The Solution:
We need a structured pathway.

• The Guide: The news should ideally be delivered by a kidney specialist who knows the whole story.
• The Compass: The explanation needs to be clear, accurate, and kind.
• The Support Team: Immediately after the news, there should be a counselor or support system ready to help the patient process the emotions and get connected to the right care.

In short: Finding out you have a genetic disease is like being dropped into the middle of a maze. Right now, too many people are being dropped in by someone who doesn't know the way out. This paper argues we need to hand them a guide, a map, and a friend to walk with them.

Technical Summary

Technical Summary: Patient-Reported Diagnostic Pathways and Disclosure Experiences in ADPKD

1. Problem Statement
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a prevalent genetic disorder, yet the practices surrounding its diagnostic disclosure are inconsistent. There is a critical gap in understanding how the setting and provider of the initial diagnosis (e.g., radiologist vs. nephrologist) influence the patient's psychological experience, the perceived quality of communication ("tact"), and their subsequent linkage to specialized nephrology care. The lack of standardized, guideline-aligned disclosure pathways may lead to suboptimal patient outcomes, including psychological distress and delayed entry into disease management programs.

2. Methodology

• Study Design: A cross-sectional, web-based survey (PK-DIAG).
• Setting & Population: Conducted in France between February 2019 and August 2024. The cohort consisted of 1,021 adults with self-reported ADPKD, recruited via patient organizations.
• Primary Outcomes:
  • Poor Tact: Defined as a score of 0–1 on a 0–5 scale regarding the manner of disclosure.
  • Very Negative Diagnostic Experience: Defined as an overall experience score of 0–1 on a 0–5 scale.
• Statistical Analysis: Multivariable logistic regression was employed using complete-case analyses to identify associations between disclosure characteristics (provider, setting, timing) and the primary negative outcomes.

3. Key Contributions
This study provides the first large-scale, patient-reported characterization of the ADPKD diagnostic journey in France. Its primary contributions include:

• Mapping Disclosure Pathways: It quantifies the frequency of diagnosis occurring outside dedicated nephrology consultations, specifically highlighting the role of radiologists.
• Quantifying Communication Quality: It establishes baseline metrics for "poor tact" and "negative experiences" in ADPKD disclosure.
• Identifying Predictors of Distress: It isolates specific modifiable factors (provider type, information clarity) that correlate strongly with negative patient experiences.

4. Key Results

• Disclosure Setting: Diagnosis was frequently delivered outside of nephrology care. Notably, 49% of respondents reported their diagnosis was delivered by a radiologist, often in a radiology setting.
• Negative Experiences:
  • 25% of participants reported "poor tact" during the disclosure.
  • 29% reported a "very negative" overall diagnostic experience.
• Associations:
  • Provider Impact: Disclosure by a radiologist (vs. a nephrologist) was significantly associated with poor tact (Adjusted Odds Ratio [aOR]: 2.50; 95% CI: 1.57–3.98).
  • Experience Drivers: A very negative overall experience was strongly associated with:
    • Poor tact (aOR: 4.55; 95% CI: 2.90–7.12).
    • Information perceived as insufficient, unclear, or inaccurate (aOR: 2.52; 95% CI: 1.53–4.15).
• Timing and Psychological Impact:
  • While 67% perceived the timing as appropriate, 18% felt it was too early and 15% too late.
  • Immediate post-disclosure psychological burden was high: 36% reported distress and 40% reported unmet psychological needs.

5. Significance and Implications
The findings underscore a systemic disconnect between the diagnostic detection of ADPKD (often incidental via imaging) and the delivery of the diagnosis. The data suggests that non-specialist providers (radiologists) may lack the specific training or protocols to deliver complex genetic diagnoses with the necessary tact and context.

Clinical and Policy Recommendations:

• Structured Pathways: There is an urgent need for standardized, guideline-aligned disclosure protocols that ensure the diagnosis is communicated by or in close coordination with nephrology specialists.
• Integrated Support: Diagnostic encounters should incorporate immediate psychosocial support and counseling to address the high rates of distress and unmet needs observed.
• Rapid Linkage: Systems must be established to facilitate the rapid transition from diagnosis to specialized nephrology care, preventing patients from falling through the cracks of the healthcare system.

In conclusion, the study advocates for a shift from incidental, provider-dependent disclosure to a patient-centered, multidisciplinary approach that prioritizes communication quality and psychological well-being at the moment of diagnosis.